DC-SIGNR/CD299/CLEC4M Antibody (MM0241-2U25) - Azide and BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-12158
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
Block/Neutralize, CyTOF-ready, Flow Cytometry, Immunohistochemistry
Label
Unconjugated
Antibody Source
Monoclonal Mouse IgG2 Clone # MM0241-2U25
Format
Azide and BSA Free
Concentration
LYOPH mg/ml
Product Summary for DC-SIGNR/CD299/CLEC4M Antibody (MM0241-2U25) - Azide and BSA Free
Immunogen
Human recombinant DC-SIGNR/CD299/CLEC4M
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2
Applications for DC-SIGNR/CD299/CLEC4M Antibody (MM0241-2U25) - Azide and BSA Free
Application
Recommended Usage
Flow Cytometry
1:10-1:1000
Immunohistochemistry
1:50-1:100
Application Notes
This antibody is Cytof ready.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein G purified
Reconstitution
Reconstitute with sterilized PBS to a final concentration of 0.5 mg/ml.
Formulation
Lyophilized from a 0.2 um filtered solution in PBS. 0.025 mg size is provided in liquid form, PBS
Format
Azide and BSA Free
Preservative
No Preservative
Concentration
LYOPH mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: DC-SIGNR/CD299
Long Name
Dendritic Cell-specific ICAM-3-grabbing Non-integrin 2
Alternate Names
CD209L, CD299, CLEC4M, DC-SIGN2, DCSIGNR, LSIGN
Gene Symbol
CLEC4M
UniProt
Additional DC-SIGNR/CD299 Products
Product Documents for DC-SIGNR/CD299/CLEC4M Antibody (MM0241-2U25) - Azide and BSA Free
Product Specific Notices for DC-SIGNR/CD299/CLEC4M Antibody (MM0241-2U25) - Azide and BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...